Abstract:Background: Metabolic abnormalities have been widely studied in women with polycystic ovary syndrome (PCOS) and in patients with Type 2 diabetes mellitus (T2DM). However, there are few studies on the comparison of the metabolic disturbances between the two diseases although they have partly common pathogenesis. This study compares the metabolic parameters of PCOS and T2DM, and evaluates the association between metabolic parameters and gonadotropic hormones. Methods: Fifity newly diagnosed PCOS women and 56 newly diagnosed Type 2 diabetes women were enrolled in the study. The metabolic parameters including body mass index, waist to hip ratio, blood pressure, total cholesterol, triglycerides, high-density and low-density lipoprotein cholesterol, fasting and postprandial plasma glucose, fasting and postprandial plasma insulin, HOMA-IR index and uric acid, along with the gonadal and gonadotropic hormones were analyzed between the two groups. The lutein hormone (LH) responses to the GnRH stimulating test were compared between different glucose tolerance groups in PCOS women. The peak values of LH in the GnRH test are studied with metabolic parameters using Pearson correlation analysis. Results: PCOS patients have higher body weight index, waist to hip ratio, fasting and postprandial insulin, HOMA-IR and uric acid than T2DM patients. There are no significant differences in lipid metabolism excluding the age influence. On the other hand, T2DM patients have significantly higher systolic blood pressure and plasma glucose than those in PCOS patients. But there is less clinical significance in the level of plasma glucose. After GnRH injection in PCOS women, there are significant differences in LH reaction between the three groups with different glucose tolerance. Conclusion: Women with PCOS have more severe metabolic disturbance than women with T2DM except for systolic blood pressure. Insulin resistance affects the function of thalamus-pituitary-gonad axis.

Advance in Research on Polycystic Ovary Syndrome and Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus and Polycystic Ovary Syndrome

Research Progress of Relationship between Type 1 Diabetes Mellitus and Polycystic Ovary Syndrome

Advances in Molecular Genetic Study on PCOS

Type 2 Diabetes Mellitus in Patients With Polycystic Ovary Syndrome

[Advance in treatment of polycystic ovary syndrome]

Polycystic ovary syndrome and type 1 diabetes — the current state of knowledge

Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

Research advances of gastrointestinal hormones and polycystic ovary syndrome

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome

[Research Progress in the Pathogenesis of Polycystic Ovary Syndrome]

More attention should be paid to metabolic disorders in polycystic ovary syndrome

Advances in Mitochondrial Dysfunction in Women with Polycystic Ovary Syndrome

Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)

Update on the management of polycystic ovary syndrome

Advance about Metformin in Treating Polycystic Ovary Syndrome

Differences and Similarities Between Abnormal Glucose Tolerance of PCOS and T2DM

Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature

Comparison of Metabolic Abnormalities in Patients with New-Diagnostic Polycystic Ovary Syndrome and with New-Diagnostic Type 2 Diabetes Mellitus

Research status of polycystic ovary syndrome and endometrial hyperplasia

Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment